
Market
Cadence Rakes In $100M to Automate Chronic Care at Scale
Cadence, an AI-powered chronic care platform, raised $100 million in Series C funding at a $1.23 billion valuation. The company's software monitors patients at home and adjusts medications in real time for heart failure, hypertension, and diabetes management through partnerships with health systems.
The source
This brief is a MedIndexer summary of reporting by MedCity News. To read the full story, head to the source.
Read the full story at MedCity News